Curated oncology deal flow
Oncology startups, scaleups and research projects, each one reviewed by our team — with a members-only view for approved investors and corporates, and a say in who pitches.
Curated deal flow — and a real say in who pitches.
The members-only catalogue detail, a vote on the finalists — run offline by our team for now — and the right to put questions to finalists at every event, for approved investors and corporates.
Curated deal flow
Every innovator on End Cancer is oncology-focused and approved by our team before it is listed, and once you have an account you can request an introduction from an innovator's page. Approved investors and corporates also see the members-only detail a startup or scaleup adds — pitch deck, traction and financials.
Vote on finalists
Approved investors and corporates help choose the five startups and five scaleups that pitch at each event. For now the vote runs offline: our team organises it with you directly, not through this website.
Ask questions live
Investors and corporates put their questions to the finalists during the pitch competition.
Investors & corporates on End Cancer
Approved investors and corporates who chose to be listed — name and basics only, never contact details.
No investors or corporates are listed yet
Approved investors and corporates appear here once they choose to be listed in their profile. Register to join them.